KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Short term Debt (2017 - 2021)

Historic Short term Debt for Co-Diagnostics (CODX) over the last 5 years, with Q3 2021 value amounting to $30000.0.

  • Co-Diagnostics' Short term Debt fell 7500.0% to $30000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $30000.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $120000.0 for FY2020, which is 0.0% changed from last year.
  • Co-Diagnostics' Short term Debt amounted to $30000.0 in Q3 2021, which was down 7500.0% from $90000.0 recorded in Q2 2021.
  • Co-Diagnostics' 5-year Short term Debt high stood at $814277.0 for Q2 2017, and its period low was $30000.0 during Q3 2021.
  • Moreover, its 5-year median value for Short term Debt was $120000.0 (2017), whereas its average is $174126.5.
  • Examining YoY changes over the last 5 years, Co-Diagnostics' Short term Debt showed a top increase of 0.0% in 2018 and a maximum decrease of 8526.3% in 2018.
  • Quarter analysis of 5 years shows Co-Diagnostics' Short term Debt stood at $120000.0 in 2017, then changed by 0.0% to $120000.0 in 2018, then changed by 0.0% to $120000.0 in 2019, then changed by 0.0% to $120000.0 in 2020, then crashed by 75.0% to $30000.0 in 2021.
  • Its Short term Debt was $30000.0 in Q3 2021, compared to $90000.0 in Q2 2021 and $120000.0 in Q1 2021.